Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kluth

Showing results (671-680 of 1,145) with videos related to

Pageof 115
Sort By:
Scientific Reports|August 22, 2018
Author Correction: Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancerAsmus Heumann, Özge Kaya, Christoph Burdelski, et al.
Urologic Oncology|January 18, 2014
Combining smoking information and molecular markers improves prognostication in patients with urothelial carcinoma of the bladderLily C Wang, Evanguelos Xylinas, Matthew T Kent, et al.
Annals of Surgical Oncology|March 25, 2024
Perioperative Complications and In-Hospital Mortality in Partial and Radical Nephrectomy Patients with Heart-Valve ReplacementCarolin Siech, Andrea Baudo, Mario de Angelis, et al.
Annals of Surgical Oncology|February 20, 2026
Cancer-Specific Mortality in Rare Histological Subtypes of Prostate Cancer: Radical Prostatectomy Versus Radiation TherapyCarolin Siech, Mario de Angelis, Letizia Maria Ippolita Jannello, et al.
Stem Cell Research & Therapy|March 20, 2021
Process development and safety evaluation of ABCB5<sup>+</sup> limbal stem cells as advanced-therapy medicinal product to treat limbal stem cell deficiencyAlexandra Norrick, Jasmina Esterlechner, Elke Niebergall-Roth, et al.
Surgical Oncology|May 23, 2022
Metastatic stage vs complications at radical nephrectomy with inferior vena cava thrombectomyBenedikt Hoeh, Rocco Simone Flammia, Lukas Hohenhorst, et al.
World Journal of Urology|September 25, 2013
Association of diabetes mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostate cancerMalte Rieken, Luis A Kluth, Evanguelos Xylinas, et al.
European Urology|October 22, 2013
Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over timeGuillaume Ploussard, Shahrokh F Shariat, Alice Dragomir, et al.
Oncotarget|November 12, 2016
p16 overexpression and 9p21 deletion are linked to unfavorable tumor phenotype in breast cancerPatrick Lebok, Magdalena Roming, Martina Kluth, et al.
World Journal of Urology|February 11, 2018
Immunohistochemically detected IDH1<sup>R132H</sup> mutation is rare and mostly heterogeneous in prostate cancerAndrea Hinsch, Meta Brolund, Claudia Hube-Magg, et al.
Pageof 115

Showing results (671-680 of 1,145) with videos related to

Sort By:
Pageof 115
Scientific Reports|August 22, 2018
Author Correction: Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancerAsmus Heumann, Özge Kaya, Christoph Burdelski, et al.
Urologic Oncology|January 18, 2014
Combining smoking information and molecular markers improves prognostication in patients with urothelial carcinoma of the bladderLily C Wang, Evanguelos Xylinas, Matthew T Kent, et al.
Annals of Surgical Oncology|March 25, 2024
Perioperative Complications and In-Hospital Mortality in Partial and Radical Nephrectomy Patients with Heart-Valve ReplacementCarolin Siech, Andrea Baudo, Mario de Angelis, et al.
Annals of Surgical Oncology|February 20, 2026
Cancer-Specific Mortality in Rare Histological Subtypes of Prostate Cancer: Radical Prostatectomy Versus Radiation TherapyCarolin Siech, Mario de Angelis, Letizia Maria Ippolita Jannello, et al.
Stem Cell Research & Therapy|March 20, 2021
Process development and safety evaluation of ABCB5<sup>+</sup> limbal stem cells as advanced-therapy medicinal product to treat limbal stem cell deficiencyAlexandra Norrick, Jasmina Esterlechner, Elke Niebergall-Roth, et al.
Surgical Oncology|May 23, 2022
Metastatic stage vs complications at radical nephrectomy with inferior vena cava thrombectomyBenedikt Hoeh, Rocco Simone Flammia, Lukas Hohenhorst, et al.
World Journal of Urology|September 25, 2013
Association of diabetes mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostate cancerMalte Rieken, Luis A Kluth, Evanguelos Xylinas, et al.
European Urology|October 22, 2013
Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over timeGuillaume Ploussard, Shahrokh F Shariat, Alice Dragomir, et al.
Oncotarget|November 12, 2016
p16 overexpression and 9p21 deletion are linked to unfavorable tumor phenotype in breast cancerPatrick Lebok, Magdalena Roming, Martina Kluth, et al.
World Journal of Urology|February 11, 2018
Immunohistochemically detected IDH1<sup>R132H</sup> mutation is rare and mostly heterogeneous in prostate cancerAndrea Hinsch, Meta Brolund, Claudia Hube-Magg, et al.
Pageof 115